11.11.2015 • News

Nov. 18 Closing for Sigma-Aldrich Takeover by Merck KGaA

Nov. 18 Closing for Sigma-Aldrich Takeover by Merck KGaA
Nov. 18 Closing for Sigma-Aldrich Takeover by Merck KGaA

The European Commission has approved the sale of Sigma-Aldrich’s solvents and inorganics business in Europe to Honeywell, finally clearing the path for the US company’s acquisition by Germany’s Merck KGaA for $17 billion. The closing is now scheduled for Nov.18.

Honeywell is paying about €105 million for the assets, which will be integrated into its Fine Chemicals unit. Following completion of the takeover, first announced in September 2014, Sigma-Aldrich’s stock will be delisted from the US NASDAQ exchange.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.